AP Biosciences, Inc. (6945) Stock Statistics & Valuation Metrics
Total Valuation
AP Biosciences, Inc. has a market cap or net worth of TWD 10.92B. The enterprise value is TWD 6.86B.
- Market Cap
- TWD 10.92B
- Enterprise Value
- TWD 6.86B
Share Statistics
AP Biosciences, Inc. has 97,531,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 97,531,160
- Owned by Insiders
- ―
- Owned by Institutions
- 0.05%
Financial Efficiency
AP Biosciences, Inc.’s return on equity (ROE) is -0.35 and return on invested capital (ROIC) is -34.16%.
- Return on Equity (ROE)
- -0.35
- Return on Assets (ROA)
- -0.33
- Return on Invested Capital (ROIC)
- -34.16%
- Return on Capital Employed (ROCE)
- -0.34
- Revenue Per Employee
- 0
- Profits Per Employee
- -12.02M
- Employee Count
- 37
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of AP Biosciences, Inc. is -20.93. AP Biosciences, Inc.’s PEG ratio is 1.33.
- PE Ratio
- -20.93
- PS Ratio
- 0.00
- PB Ratio
- 4.24
- Price to FCF
- -28.79
- Price to Operating Cash Flow
- -26.98
- PEG Ratio
- 1.33
Income Statement
In the last 12 months, AP Biosciences, Inc. had revenue of 0 and earned -444.77M in profits. Earnings per share was -5.23.
- Revenue
- 0
- Gross Profit
- -25.52M
- Operating Income
- -456.38M
- Pretax Income
- -444.77M
- Net Income
- -444.77M
- EBITDA
- -430.86M
- Earnings Per Share (EPS)
- -5.23
Cash Flow
In the last 12 months, operating cash flow was -365.80M and capital expenditures -16.99M, giving a free cash flow of -382.79M billion.
- Operating Cash Flow
- -365.80M
- Free Cash Flow
- -382.79M
- Free Cash Flow per Share
- -4.38
Dividends & Yields
AP Biosciences, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.50%
- Earnings Yield
- -4.75%
Stock Price Statistics
- Beta
- 0.77
- 52-Week Price Change
- -5.08%
- 50-Day Moving Average
- 122.29
- 200-Day Moving Average
- 139.81
- Relative Strength Index (RSI)
- 38.22
- Average Volume (3m)
- 403.22K
Important Dates
AP Biosciences, Inc. upcoming earnings date is Dec 21, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 11, 2026
- Next Earnings Date
- Dec 21, 2026
- Ex-Dividend Date
- ―
Financial Position
AP Biosciences, Inc. as a current ratio of 29.94, with Debt / Equity ratio of 4.68%
- Current Ratio
- 29.94
- Quick Ratio
- 29.94
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 2.12
- Interest Coverage Ratio
- -320.49
Taxes
In the past 12 months, AP Biosciences, Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
AP Biosciences, Inc. EV to EBITDA ratio is -21.58, with an EV/FCF ratio of -27.91.
- EV to Sales
- 0.00
- EV to EBITDA
- -21.58
- EV to Free Cash Flow
- -27.91
- EV to Operating Cash Flow
- -29.20
Balance Sheet
AP Biosciences, Inc. has TWD 2.19B in cash and marketable securities with TWD 53.73M in debt, giving a net cash position of TWD 2.14B billion.
- Cash & Marketable Securities
- TWD 2.19B
- Total Debt
- TWD 53.73M
- Net Cash
- TWD 2.14B
- Net Cash Per Share
- TWD 21.95
- Tangible Book Value Per Share
- TWD 26.59
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
